Literature DB >> 9052721

Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.

J M Benito1, J M Zabay, J Gil, M Bermejo, A Escudero, E Sánchez, E Fernández-Cruz.   

Abstract

We determined the representation in asymptomatic human immunodeficiency virus (HIV) infection of the CD45RO+ and CD45RO- CD45RA+ subsets of CD4+ and CD8+ T lymphocytes, CD11b+ and CD11b- subsets of CD8+ T cells, and activated populations of these subsets. Three-color flow cytometry was used to quantitate the different CD4+ and CD8+ T cell populations in 116 asymptomatic HIV+ individuals. In asymptomatic HIV+ infection there was a significant relative increase in the CD4+ CD45RO+ and CD8+ CD45RO+ T cell subsets, which express CD38 and DR antigens, that correlated strongly with the decline in total CD4+ T cells. In addition, we found a loss of CD4+ CD45RO- and CD8+ CD45RO- T cells associated with progression of HIV infection (as measured by the decline in total CD4+ T cells). Studies presented here also indicate that, with the progression of asymptomatic HIV infection, CD8+ CD11b- T lymphocytes showed a significant decrease, whereas CD8+ CD11b+ T cells were significantly increased. This study demonstrates that the progression of HIV infection in asymptomatic patients involves the increase in CD45RO+ subsets of CD4+ and CD8+ T cells, the increase in CD8+ CD11b+ T cells, the decrease in CD45RO- CD45RA+ subsets of CD4 and CD8 T cells, and the decline in CD8+ CD11b- T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052721     DOI: 10.1097/00042560-199702010-00005

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  25 in total

Review 1.  Current concepts in human immunodeficiency virus infection and AIDS.

Authors:  S A Schwartz; M P Nair
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  CD45RA and CD45RO isoforms in infected malnourished and infected well-nourished children.

Authors:  O Nájera; C González; G Toledo; L López; E Cortés; M Betancourt; R Ortiz
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  T cell signaling mechanisms that regulate HIV-1 infection.

Authors:  D Unutmaz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.

Authors:  Ruy M Ribeiro; Mette D Hazenberg; Alan S Perelson; Miles P Davenport
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 6.  Immune activation in the context of HIV infection.

Authors:  Z Bentwich; A Kalinkovich; Z Weisman; Z Grossman
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Abnormal CD40 ligand (CD154) expression in human immunodeficiency virus-infected children.

Authors:  M R O'Gorman; B DuChateau; M Paniagua; J Hunt; N Bensen; R Yogev
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

8.  Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.

Authors:  S Imlach; S McBreen; T Shirafuji; C Leen; J E Bell; P Simmonds
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Authors:  Angélique Biancotto; Jean-Charles Grivel; Sarah J Iglehart; Christophe Vanpouille; Andrea Lisco; Scott F Sieg; Robert Debernardo; Kristen Garate; Benigno Rodriguez; Leonid B Margolis; Michael M Lederman
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

10.  Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

Authors:  A Kalinkovich; Z Weisman; Z Greenberg; J Nahmias; S Eitan; M Stein; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.